Maximilian Kopp

504 total citations
8 papers, 420 citations indexed

About

Maximilian Kopp is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Maximilian Kopp has authored 8 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Physiology. Recurrent topics in Maximilian Kopp's work include Diabetes Treatment and Management (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Receptor Mechanisms and Signaling (2 papers). Maximilian Kopp is often cited by papers focused on Diabetes Treatment and Management (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Receptor Mechanisms and Signaling (2 papers). Maximilian Kopp collaborates with scholars based in Germany, France and Austria. Maximilian Kopp's co-authors include Thomas Münzel, Andreas Daiber, Swenja Kröller‐Schön, Matthias Oelze, Sebastian Steven, Philip Wenzel, Siyer Roohani, F. Ravandi Kashani, Philipp Welschof and Eberhard Schulz and has published in prestigious journals such as PLoS ONE, Brain Research and Free Radical Biology and Medicine.

In The Last Decade

Maximilian Kopp

8 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maximilian Kopp Germany 7 226 156 129 87 75 8 420
Munenori Hiromura Japan 13 314 1.4× 175 1.1× 202 1.6× 52 0.6× 91 1.2× 30 505
Seth Truran United States 12 114 0.5× 214 1.4× 63 0.5× 117 1.3× 90 1.2× 23 450
Meghan Sauvé Canada 5 353 1.6× 185 1.2× 151 1.2× 56 0.6× 108 1.4× 5 541
Naomitsu Kuwamura Japan 7 248 1.1× 282 1.8× 114 0.9× 44 0.5× 114 1.5× 7 490
Stefanie Ruhs Germany 13 224 1.0× 235 1.5× 88 0.7× 34 0.4× 73 1.0× 23 471
Colleen Pineda United States 2 336 1.5× 114 0.7× 97 0.8× 33 0.4× 78 1.0× 2 445
Yoichi Hamada Japan 11 273 1.2× 175 1.1× 143 1.1× 175 2.0× 200 2.7× 19 668
Iresha Welungoda Australia 6 339 1.5× 206 1.3× 99 0.8× 35 0.4× 215 2.9× 7 475
Péter Degrell Hungary 13 87 0.4× 156 1.0× 62 0.5× 42 0.5× 40 0.5× 26 392
Xiaojing Ma China 9 103 0.5× 160 1.0× 78 0.6× 46 0.5× 42 0.6× 13 393

Countries citing papers authored by Maximilian Kopp

Since Specialization
Citations

This map shows the geographic impact of Maximilian Kopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian Kopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian Kopp more than expected).

Fields of papers citing papers by Maximilian Kopp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximilian Kopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian Kopp. The network helps show where Maximilian Kopp may publish in the future.

Co-authorship network of co-authors of Maximilian Kopp

This figure shows the co-authorship network connecting the top 25 collaborators of Maximilian Kopp. A scholar is included among the top collaborators of Maximilian Kopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximilian Kopp. Maximilian Kopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kopp, Maximilian, et al.. (2019). Femtosecond laser induced step-like structures inside transparent hydrogel due to laser induced threshold reduction. PLoS ONE. 14(9). e0222293–e0222293. 6 indexed citations
2.
Oelze, Matthias, Philipp Welschof, Maike Knorr, et al.. (2017). Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and Valsartan. Pharmacology. 101(1-2). 54–63. 1 indexed citations
3.
Steven, Sebastian, Matthias Oelze, Alina Hanf, et al.. (2017). The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats. Redox Biology. 13. 370–385. 243 indexed citations
4.
Hanf, Alina, Sebastian Steven, Matthias Oelze, et al.. (2017). The SGLT2 Inhibitor Empagliflozin Improves the Primary Diabetic Complications in ZDF Rats. Free Radical Biology and Medicine. 112. 112–113. 6 indexed citations
5.
Steven, Sebastian, Kerstin Jurk, Maximilian Kopp, et al.. (2016). Glucagon‐like peptide‐1 receptor signalling reduces microvascular thrombosis, nitro‐oxidative stress and platelet activation in endotoxaemic mice. British Journal of Pharmacology. 174(12). 1620–1632. 83 indexed citations
6.
Jabs, Alexander, Matthias Oelze, Yuliya Mikhed, et al.. (2015). Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats. Vascular Pharmacology. 71. 181–191. 28 indexed citations
7.
Stamm, Paul, Alexander Jabs, Matthias Oelze, et al.. (2015). Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats. BMC Pharmacology and Toxicology. 16(S1). 7 indexed citations
8.
Szabolcs, Matthias, et al.. (1989). Carbonic anhydrase activity in the peripheral nervous system of rat: the enzyme as a marker for muscle afferents. Brain Research. 492(1-2). 129–138. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026